http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
-
NovaBay Pharmaceuticals to Present at Two Investment Conferences in September
-
NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock
-
NovaBay Pharma (NBY) Prices 4.2M Shares Registered Direct Offering at $1/Sh
-
NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering
-
NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results
-
NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million
-
NovaBay Pharmaceuticals Issues Letter to Stockholders
-
NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE
-
NovaBay Pharma (NBY) Raises $2.4 Million in Private Placement of Common Stock, Warrants
-
NovaBay Pharmaceuticals Raises $2.4 Million in a Private Placement
-
NioBay Reports Initial Resource Estimate for Its James Bay Niobium Project
-
NioBay and Midland Commence Drilling Campaign on La Peltrie
-
NioBay Announces Option to Acquire up to 65% in the La Peltrie Gold Project From Midland Exploration, Southeast of Detour Gold's Zone 58N
-
NioBay Metals provides an update on the exploration permit application at the James Bay Niobium project
-
NioBay Metals announces initial metallurgical test results from its James Bay Niobium Project and Upcoming Information session at Moosonee
-
NioBay Metals provides further results from re-assaying program at James Bay Niobium Project
-
NioBay Metals provides initial results from re-assaying program at James Bay Niobium Project
-
Niobay Metals Announces Adoption of New Stock Option Plan
-
Niobay Metals announces Closing of Flow Through Financing
-
Niobay Metals announces Flow-Through Financing of up to $1,000,000
-
NovaBay Pharmaceuticals Reports 2016 First Quarter Financial Results
-
NovaBay Pharma (NBY) Announces $2.83M Private Placement
-
NovaBay Pharmaceuticals Announces $2.83 Million Private Placement
-
Pre-Open Stock Movers 06/04: (BRLI) (AVEO) (FIVE) Higher; (MCP) (DRWI) (OPK) Lower (more...)
-
NovaBay’s Avenova Featured in Ophthalmology Management
-
Photo Release -- NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek, Solta Medical Chairman and CEO and Dr. Massimo Radaelli, Noventia Pharma CEO to Its Board of Directors

